On January 13, 2025, Big Pharma Split Corp. announced an at-the-market (ATM) equity offering of up to $150 million, split equally between Preferred Shares and Class A Shares. The shares are listed on the Toronto Stock Exchange under "PRM.PR.A" and "PRM." National Bank Financial Inc. is acting as the agent, earning a 2.5% commission on gross proceeds.

Proceeds will fund investments in a portfolio of major North American pharmaceutical companies. Legal advisors include Blake, Cassels & Graydon LLP for the company and McCarthy Tétrault LLP for the agent. The offering expires in February 2027 or when fully sold. Net asset value per unit as of January 10, 2025, was $21.83.